-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Surgical scene (Photo courtesy of Shanghai Tenth Hospital)
Atrial fibrillation is one of the "culprits" that lead to stroke and heart failure
"Whether it is a stroke or heart failure, the consequences are very serious, ranging from affecting the quality of life, and at worst, life-threatening
At present, the clinical treatment of atrial fibrillation mainly adopts antiarrhythmic drugs to control symptoms, and thermal ablation to "burn" the abnormal electrical signals in the heart
While learning foreign treatment experience, Xu Yawei's team pioneered a more personalized and precise "AF-PACC strategy" with Chinese medical characteristics and suitable for Chinese patients with atrial fibrillation, namely: for atrial fibrillation (AF, atrial fibrillation) fibrilltion) comprehensive evaluation, flexible use of physiological pacing (Pace), AV ablation (Ablation/AV node), left atrial appendage closure (Closure), cryo/catheter ablation (Cryo/Catheter) and other treatment methods
Xu Yawei said that this treatment strategy can help the majority of patients to formulate more personalized and accurate diagnosis and treatment plans, so as to effectively deal with the risks of atrial fibrillation recurrence, ischemic stroke, and deterioration of cardiac function, and realize the whole process of atrial fibrillation diagnosis and treatment loop closure.
At present, the atrial fibrillation center of Shanghai No.
"We can accurately assess all patients with atrial fibrillation, and give patients individualized treatment options.